Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
PFE [NYSE]
Pfizer Inc.
IndexDJIA S&P500 P/E18.13 EPS (ttm)1.64 Insider Own0.10% Shs Outstand6.37B Perf Week-2.49%
Market Cap189.45B Forward P/E13.16 EPS next Y2.26 Insider Trans10.07% Shs Float6.37B Perf Month0.20%
Income11.03B PEG6.09 EPS next Q0.57 Inst Own80.40% Short Float0.96% Perf Quarter-5.56%
Sales50.53B P/S3.75 EPS this Y37.50% Inst Trans12.65% Short Ratio2.31 Perf Half Y-0.57%
Book/sh12.17 P/B2.44 EPS next Y0.71% ROA23.50% Target Price34.65 Perf Year4.02%
Cash/sh5.32 P/C5.59 EPS next 5Y2.98% ROE52.80% 52W Range27.08 - 32.67 Perf YTD-1.26%
Dividend1.04 P/FCF18.34 EPS past 5Y6.80% ROI10.50% 52W High-10.55% Beta0.68
Dividend %3.50% Quick Ratio2.10 Sales past 5Y1.30% Gross Margin81.90% 52W Low7.92% ATR0.42
Employees77700 Current Ratio2.30 Sales Q/Q-8.50% Oper. Margin34.00% RSI (14)34.68 Volatility1.39% 1.36%
OptionableYes Debt/Eq0.48 EPS Q/Q-2.80% Profit Margin81.20% Rel Volume1.22 Prev Close29.73
ShortableYes LT Debt/Eq0.36 EarningsJul 29 BMO Payout16.40% Avg Volume26.42M Price29.22
Recom2.30 SMA20-3.60% SMA50-2.14% SMA200-3.98% Volume26,824,256 Change-1.72%
02-Jul-13Downgrade Standpoint Research Hold → Sell $24
15-Apr-13Reiterated Barclays Equal Weight $25 → $32
30-Jan-13Reiterated UBS Buy $29 → $31
30-Jan-13Reiterated Argus Buy $28 → $32
22-Jan-13Reiterated Barclays Equal Weight $24 → $25
27-Nov-12Downgrade MKM Partners Buy → Neutral $29 → $25
05-Oct-12Reiterated MKM Partners Buy $27 → $29
01-Nov-11Downgrade Standpoint Research Buy → Hold
07-Oct-11Initiated MKM Partners Buy $20.50
14-Sep-11Downgrade Barclays Capital Overweight → Equal Weight $21 → $19
10-Aug-11Upgrade Argus Hold → Buy $21
05-Aug-11Upgrade Standpoint Research Hold → Buy $21
14-Mar-11Downgrade Standpoint Research Buy → Hold
03-Nov-10Downgrade Argus Buy → Hold
21-May-10Initiated Jefferies Buy $17.80
16-Dec-09Initiated UBS Buy
27-Apr-09Initiated Standpoint Research Buy $20
12-Feb-09Upgrade Leerink Swann Mkt Perform → Outperform
09-Feb-09Upgrade UBS Neutral → Buy
02-Feb-09Upgrade Credit Suisse Neutral → Outperform
30-Jul-14 01:16PM  Top defensive picks in offensive sectors Yahoo Finance
12:39PM  Pfizer buying two Baxter vaccines for $635M AP
10:33AM  InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada PR Newswire
10:22AM  Why Pfizer (PFE) Stock Is Down Today at TheStreet
09:38AM  Pfizer to buy Baxter's vaccines unit for $635 mln Reuters
08:32AM  Pfizer to buy Baxters vaccines for $635 million at MarketWatch
08:25AM  Pfizer to buy two Baxter vaccines for $635 mln Reuters
08:20AM  Amgen Beats on Q2 Earnings & Revs, Ups View & Plans Job Cuts Zacks
08:19AM  [$$] Pfizer To Buy Baxter's Vaccines at The Wall Street Journal
08:00AM  Pfizer Enters Into Agreement to Acquire Baxters Portfolio of Marketed Vaccines Business Wire
07:35AM  #PreMarket Primer: Wednesday, July 30: U.S. Economy Showing Signs Of Strength Benzinga
07:07AM  AstraZeneca to bolster respiratory drugs with Almirall deal at Financial Times
05:20AM  AstraZeneca to Pay Up to $2.1 Billion For Respiratory Drugs at New York Times
05:20AM  AstraZeneca to Pay up to $2.1 Billion For Respiratory Drugs at New York Times
05:20AM  AstraZeneca to Pay Almirall Up to $2.1 Billion for Respiratory Drugs at New York Times
12:51AM  [$$] Pfizer Still Looking to Buy at The Wall Street Journal
12:27AM  [$$] Pfizer Still Looking to Buy at The Wall Street Journal
29-Jul-14 10:59PM  [$$] Pfizer Still Looking to Buy at The Wall Street Journal
08:54PM  [$$] Pfizer Still Looking to Buy at The Wall Street Journal
07:15PM  Stocks close lower as global tensions take a toll at USA TODAY
05:46PM  Stocks close lower as global tensions take a toll at USA TODAY
05:37PM  Stocks close lower as global tensions take a toll at USA TODAY
05:32PM  Merck, Pfizer Ramping R&D After Q2 Earnings Beat at Investor's Business Daily
04:24PM  Stocks close lower as global tensions take a toll at USA TODAY
04:24PM  Pfizer leaves investors guessing on intentions for Astra Reuters
04:18PM  [$$] Pfizer Still Looking to Buy at The Wall Street Journal
03:50PM  Stocks mixed as Dow slides further from 17,000 at USA TODAY
03:46PM  Pfizer Traders Fickle on Stock After Q2 Beat StockTwits
03:40PM  Pfizer CEO: Shareholders Happy with Price Discipline on AstraZeneca at The Wall Street Journal
02:33PM  Stocks mixed as Dow fights for 17,000 at USA TODAY
02:30PM  [$$] Pfizer Still Looking to Buy at The Wall Street Journal
02:15PM  [video] Pfizer and Merck Top Quarterly Earnings Expectations, Shares Rise at TheStreet
01:37PM  Pfizer's 2Q profit sinks 79 pct but tops forecasts AP
01:28PM  Stocks slightly higher as Dow fights for 17,000 at USA TODAY
01:00PM  Treasury prices steady after 5-year notes auction at CNBC
12:46PM  Merck Pops On Good Profits, Tax Deal? at Barrons.com
12:40PM  Pfizer leaves investors guessing on intentions for Astra Reuters
12:28PM  Treasurys mostly flat ahead of 5-year note auction at CNBC
12:09PM  [video] Pfizer CEO to CNBC: Tax reform would bring jobs back to US at CNBC
12:08PM  [video] U.S. Stocks Mixed on Geopolitical Worries Despite Upbeat Consumer at TheStreet
12:05PM  Stocks give back gains on rising global fears at USA TODAY
11:30AM  Stocks mixed as earnings compete with global worries at USA TODAY
11:29AM  [video] Stocks Start Higher as Investors React Positively to Earnings at TheStreet
11:23AM  Merck, Pfizer Beat Q2 Earnings Estimates at Investor's Business Daily
11:10AM  Pfizer, Merck earnings beat Wall St. estimates at USA TODAY
11:00AM  Dow Component Pfizer (PFE) To Go Ex-dividend Tomorrow at TheStreet
10:31AM  Stocks Climb In Early Trade; Herbalife, El Pollo Loco Dive at Investor's Business Daily
10:25AM  Treasurys pare gains after consumer confidence at CNBC
10:14AM  [video] Merck & Pfizer beat the Street at CNBC
09:49AM  Stocks rise on strong earnings; Dow above 17,000 at USA TODAY
09:38AM  Pfizer Beats on Q2 Earnings, Revs Despite Generic Pressures Zacks
09:35AM  Treasury prices rise on housing data ahead of Fed at CNBC
09:03AM  UPS delivers a profit miss; Darden CEO steps down; Herbalife tumbles Hot Stock Minute
09:03AM  'Do Drug Companies Make Drugs, Or Money?' at Forbes
09:03AM  "Do Drug Companies Make Drugs, Or Money?" at Forbes
08:49AM  [video] Cramer: Windstream interesting at CNBC
08:47AM  Pfizer's 2Q profit sinks 79 pct but tops forecasts AP
08:37AM  PFIZER INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
08:29AM  Pfizer's 2Q profit sinks 79 pct but tops forecasts AP
08:22AM  Pfizer, Merck earnings beat Wall St. estimates at USA TODAY
08:04AM  [video] Big pharma tax attack at CNBC
08:03AM  Pfizer, Merck earnings beat Wall St. estimates at USA TODAY
07:59AM  Twitter earnings preview; Argentina debt deadline; More than 1 in 3 facing debt collection Hot Stock Minute
07:47AM  [$$] Pfizer Results Beat Estimates at The Wall Street Journal
07:47AM  Early movers: UPS, MRK, PFE, MCD, DRI, HLF & more at CNBC
07:37AM  Pfizer's 2Q profit sinks 79 pct but tops forecasts AP
07:32AM  [video] Merck Earnings, Twitter User Growth & EPS, Jim Cramer's New Vale Pick at TheStreet
07:28AM  Pfizer beats forecasts as oncology drugs grow Reuters
07:21AM  [$$] Pfizer Results Beat Estimates at The Wall Street Journal
07:11AM  Pfizers Drug Sales Fall Short as Viagra Struggles at Bloomberg
07:07AM  Q2 2014 Pfizer Earnings Release - Before Market Open CCBN
07:00AM  Pfizer posts earnings of 58 cents a share vs. 57 cents estimate at CNBC
07:00AM  PFIZER REPORTS SECOND-QUARTER 2014 RESULTS Business Wire
07:00AM  European Commission Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE Business Wire
28-Jul-14 11:06PM  [$$] Wanted: Startups in Biotech at The Wall Street Journal
04:38PM  Stocks: Dow ends the day in positive territory at USA TODAY
04:36PM  Why the Fed could start raising rates sooner than you think at CNBC
04:25PM  Stocks: Dow ends the day in positive territory at USA TODAY
04:20PM  [video] The Top Ten Stocks for July 28 at Bloomberg
04:20PM  Is Pfizer Inc. (PFE) Poised to Beat Earnings Estimates? Zacks
04:06PM  Stocks: Dow ends the day in positive territory at USA TODAY
02:56PM  Stocks reverse course as Dow, S&P turn positive at USA TODAY
02:10PM  Business events scheduled for Tuesday AP
01:45PM  Stocks reverse course as Dow, S&P turn positive at USA TODAY
01:18PM  Pfizer Dips On BMO Downgrade at Barrons.com
01:02PM  Pfizer, Merck, Amgen Near Q2 Earnings Reports at Investor's Business Daily
12:54PM  Stocks drop as Dow faces 4th day of losses at USA TODAY
10:19AM  [video] The Top Ten Stocks for Monday, July 28 at Bloomberg
10:10AM  Why Pfizer (PFE) Stock Is Lower Today at TheStreet
09:21AM  Will This Analyst Downgrade Hurt Pfizer (PFE) Stock Today? at TheStreet
08:15AM  [video] Inversion shame gone: NYT reporter at CNBC
07:57AM  Tesla, Whole Foods, Pfizer and ExxonMobil are part of Zacks Earnings Preview: Zacks
06:52AM  Is a Surprise Coming for Pfizer (PFE) This Earnings Season? Zacks
04:26AM  Rumored Danone Medical Food Sale To Hospira Would End Ambition at Forbes
01:36AM  Pfizer's need for deal looms larger with earnings report Reuters
27-Jul-14 12:33PM  Week Ahead: Traders Eye Fed, GDP, Jobs, Earns, IPOs at Forbes
25-Jul-14 05:00PM  Pfizer's Incoming Patent Cliff at Motley Fool
04:05PM  What to Watch in the Week Ahead and on Monday, July 28 Reuters
03:49PM  Mark Cuban: Companies moving overseas will raise everyones taxes Yahoo Finance
12:48PM  [$$] Three Ways to Play the 'Inversion' Boom at The Wall Street Journal
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines, and various consumer healthcare products. The company's Primary Care segment offers prescription pharmaceutical products primarily prescribed by primary-care physicians for various therapeutic and disease areas comprising Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation. Its Specialty Care and Oncology segment provides prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. The company's Established Products and Emerging Markets segment offers prescription pharmaceutical products that had lost patent protection or marketing exclusivity in certain countries and/or regions, as well as sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. Its Consumer Healthcare segment provides non-prescription products in a range of therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company also offers Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Norvasc, Sutent, and the Premarin family of products; and consumer healthcare products under the Advil, Caltrate, Centrum, ChapStick, Emergen-C, Preparation H, and Robitussin brands. It serves wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, and grocery and convenience stores. It has strategic alliance with CliniWorks (Israel) Ltd. to develop population health management platform with advanced analytics and patient care capabilities. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OLSON LAURIE JExecutive Vice PresidentJun 12Option Exercise26.2036,275950,40593,010Jun 13 12:29 PM
OLSON LAURIE JExecutive Vice PresidentJun 12Sale29.5336,2751,071,27856,735Jun 13 12:29 PM
YOUNG JOHN DGroup PresidentMar 17Sale31.389,000282,42099,647Mar 18 09:33 AM
PFIZER INC10% OwnerMar 12Buy11.00272,7272,999,9971,235,330Mar 14 03:27 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale32.5967,5852,202,872173,637Mar 05 05:36 PM
Dolsten MikaelPresident R&DMar 04Sale32.5835,7891,165,929344,571Mar 05 05:36 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 04Sale32.555,082165,419171,756Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Option Exercise26.2075,5001,978,100274,699Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Sale32.0297,8613,133,674176,838Mar 05 05:37 PM
READ IAN CChairman & CEOFeb 26Option Exercise12.70324,9324,126,6361,410,536Feb 28 04:52 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise12.70130,8751,662,113312,499Feb 28 04:52 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise12.7057,586731,342116,884Feb 28 04:52 PM
BOURLA ALBERTGroup PresidentFeb 26Option Exercise12.7021,482272,82192,447Feb 28 04:52 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise12.7056,411716,420228,878Feb 28 04:52 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise12.70324,9324,126,636615,673Feb 28 04:52 PM
HILL CHARLES HExecutive Vice PresidentFeb 26Option Exercise12.7034,731441,084104,046Feb 28 04:52 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise12.7034,568439,014120,562Feb 28 04:52 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12740,480Feb 28 04:52 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12783,716Feb 28 04:52 PM
OLSON LAURIE JExecutive Vice PresidentFeb 26Option Exercise12.7031,772403,50468,167Feb 28 04:52 PM
PFIZER INC10% OwnerFeb 04Buy8.00227,2611,818,0881,794,803Feb 06 03:53 PM
DAMELIO FRANK AExecutive Vice PresidentJan 13Sale30.82131,8104,062,225356,451Jan 14 07:13 PM
DAMELIO FRANK AExecutive Vice PresidentJan 13Sale30.8628,190869,817328,261Jan 14 07:13 PM
MADDALUNA ANTHONY JExecutive Vice PresidentNov 14Option Exercise26.2092,0002,410,400152,447Nov 18 03:31 PM
MADDALUNA ANTHONY JExecutive Vice PresidentNov 14Sale32.1092,0002,953,06360,447Nov 18 03:31 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerNov 01Sale31.2010,000311,985174,841Nov 04 03:59 PM
READ IAN CChairman & CEOOct 28Option Exercise26.20338,0008,855,6001,412,267Oct 29 05:44 PM
READ IAN CChairman & CEOOct 28Sale30.57338,00010,331,3151,074,267Oct 29 05:44 PM
LANKLER DOUGLAS MExecutive Vice PresidentSep 16Option Exercise26.0660,9001,587,198150,617Sep 18 04:27 PM
LANKLER DOUGLAS MExecutive Vice PresidentSep 16Sale28.7060,9001,748,02589,717Sep 18 04:27 PM
Lewis-Hall Freda CExecutive Vice PresidentSep 16Sale28.7038,4611,103,831118,383Sep 18 04:20 PM
CORNWELL W DONDirectorAug 12Buy29.0975822,0502,217Aug 13 03:58 PM
CORNWELL W DONDirectorAug 12Sale29.0975822,0501,459Aug 13 03:58 PM
HILL CHARLES HExecutive Vice PresidentJul 31Option Exercise26.0496,5002,512,460171,362Aug 01 05:39 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerJul 31Sale29.6314,688435,180183,703Aug 01 05:39 PM
HILL CHARLES HExecutive Vice PresidentJul 31Sale29.6496,5002,860,43474,862Aug 01 05:39 PM